Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.

Andreyev, H J; Davidson, Susan E; Gillespie, C; Allum, W; Swarbrick, E

dc.contributor.author	Andreyev, H J
dc.contributor.author	Davidson, Susan E
dc.contributor.author	Gillespie, C
dc.contributor.author	Allum, W
dc.contributor.author	Swarbrick, E
dc.date.accessioned	2012-05-28T09:29:06Z	en
dc.date.available	2012-05-28T09:29:06Z	en
dc.date.issued	2012-02	en
dc.identifier.citation	Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. 2012, 61 (2):179-92 Gut	en_GB
dc.identifier.issn	1468-3288	en
dc.identifier.pmid	22057051	en
dc.identifier.doi	10.1136/gutjnl-2011-300563	en
dc.identifier.uri	http://hdl.handle.net/10541/226158	en
dc.description.abstract	BACKGOUND: The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with inflammatory bowel disease, most of these patients are not referred for gastroenterological assessment. Clinicians who do see these patients are often unaware of the benefits of targeted investigation (which differ from those required to exclude recurrent cancer), the range of available treatments and how the pathological processes underlying side effects of cancer treatment differ from those in benign GI disorders. This paper aims to help clinicians become aware of the problem and suggests ways in which the panoply of syndromes can be managed.
dc.language.iso	en	en
dc.rights	Archived with thanks to Gut	en_GB
dc.subject.mesh	Antineoplastic Agents	en
dc.subject.mesh	Biological Therapy	en
dc.subject.mesh	Gastrointestinal Diseases	en
dc.subject.mesh	Humans	en
dc.subject.mesh	Neoplasms	en
dc.subject.mesh	Radiotherapy	en
dc.subject.mesh	Surgical Procedures, Operative	en
dc.title	Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.	en
dc.type	Article	en
dc.contributor.department	Pelvic Radiation Disease and GI Unit, Royal Marsden NHS Foundation Trust, London, UK.	en_GB
dc.identifier.journal	Gut	en_GB
refterms.dateFOA	2020-04-21T09:53:57Z
html.description.abstract	BACKGOUND: The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with inflammatory bowel disease, most of these patients are not referred for gastroenterological assessment. Clinicians who do see these patients are often unaware of the benefits of targeted investigation (which differ from those required to exclude recurrent cancer), the range of available treatments and how the pathological processes underlying side effects of cancer treatment differ from those in benign GI disorders. This paper aims to help clinicians become aware of the problem and suggests ways in which the panoply of syndromes can be managed.